TABLE 1.
Strain | Bphs |
Bpss |
LD50 | Bpbs |
LD50 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carrier + 5-HT (50 mg/kg) | PTX + 5-HT at: |
Carrier + Bdk (80 mg/kg) | PTX + Bdk at: |
||||||||||||
Carrier + HA (25 mg/kg) | PTX + HA (25 mg/kg) | 50 mg/kg | 12.5 mg/kg | 3.1 mg/kg | 0.78 mg/kg | 0.39 mg/kg | 80 mg/kg | 40 mg/kg | 20 mg/kg | 10 mg/kg | |||||
SM/J | 0/4 | 4/4b | 0/4 | 4/4b | 5/5 | 5/6 | 3/6 | 0/4 | 1.0 | 0/4 | 4/4b | 2/4 | 0/4 | 0/4 | 40.0 |
SJL/J | 0/4 | 4/4b | 0/4 | 12/12c | 12/12 | 6/11 | 0/8 | 2.6 | 0/4 | 4/4b | 4/4 | 1/4 | 0/4 | 22.5 | |
AKR/J | 0/4 | 0/4 | 0/4 | 12/12c | 10/10 | 8/17 | 0/8 | 3.2 | 0/4 | 4/4b | 3/4 | 0/4 | 0/4 | 35.6 | |
MRL/MpJ | 0/4 | 0/4 | 0/4 | 4/4b | 6/6 | 4/8 | 0/4 | 2.9 | 0/4 | 2/4 | 1/4 | 0/4 | 0/4 | ||
LG/J | 0/4 | 4/4b | 0/4 | 4/4b | 7/8 | 0/4 | 5.4 | 0/4 | 2/4 | 0/4 | 0/4 | 0/4 | |||
RFM/UnNCr | 0/4 | 4/4b | 0/4 | 6/6d | 0/6 | 0/4 | 26.2 | ||||||||
PL/J | 0/4 | 4/4b | 0/4 | 6/6d | 0/8 | 0/4 | 29.8 | ||||||||
DBA/1J | 0/4 | 4/4b | 0/4 | 5/5d | 0/6 | 0/4 | 28.6 | ||||||||
SWR/J | 0/4 | 4/4b | 0/4 | 6/6d | 0/4 | 0/4 | 22.0 | ||||||||
C57BL/6J | 0/4 | 4/4b | 0/4 | 9/15 | 0/14 | 0/8 | 0/4 | 4/4b | 4/4 | 0/4 | 0/4 | 28.3 | |||
DBA/2J | 0/4 | 4/4b | 0/4 | 4/15 | 0/14 | 0/4 | 0/4 | 4/4b | 2/4 | 0/4 | 0/4 | 40.0 | |||
A/J | 0/4 | 4/4b | 0/4 | 2/15 | 0/12 | 0/4 | 0/4 | 4/4b | 2/4 | 0/4 | 0/4 | 40.0 | |||
A/HeJ | 0/4 | 4/4b | 0/4 | 3/6 | 0/6 | 0/4 | 0/4 | 4/4b | 4/4 | 2/4 | 0/4 | 20.0 | |||
NOD/LtJ | 0/4 | 4/4b | 0/4 | 2/6 | 0/8 | 0/4 | |||||||||
FVB/NCr | 0/4 | 4/4b | 0/4 | 2/6 | 0/8 | 0/4 | |||||||||
C57BL/10J | 0/4 | 4/4b | 0/4 | 1/6 | 0/4 | 0/4 | 0/4 | 2/4 | 0/4 | 0/4 | 0/4 | ||||
NZB/BlnJ | 0/4 | 4/4b | 0/4 | 3/8 | 0/6 | 0/4 | 0/4 | 4/4b | 3/4 | 2/4 | 0/4 | 22.1 | |||
NZW/LacJ | 0/4 | 4/4b | 0/4 | 2/9 | 0/6 | 0/4 | 0/4 | 4/4b | 4/4 | 2/4 | 0/4 | 20.0 | |||
129X1/SvJ | 0/4 | 4/4b | 0/4 | 6/10 | 5/14 | 1/5 | 0/4 | 0/4 | 4/4b | 3/4 | 2/4 | 0/4 | 22.1 | ||
BALB/cJ | 0/4 | 4/4b | 1/4 | 3/10 | 6/17 | 0/5 | 0/4 | 0/4 | 4/4b | 4/4 | 2/4 | 0/4 | 20.0 | ||
BALB/cByJ | 0/4 | 4/4b | 0/4 | 0/9 | 0/6 | 0/4 | 0/4 | 4/4b | 2/4 | 0/4 | 0/4 | 40.0 | |||
CBA/JCr | 0/4 | 0/4 | 0/4 | 0/8 | 0/8 | 0/4 | |||||||||
B10.D2n | 0/4 | 4/4b | 0/4 | 0/9 | 0/6 | 0/4 | 0/4 | 2/4 | 0/4 | 0/4 | 0/4 | ||||
B10.S/SgSnJ | 0/4 | 4/4b | 0/4 | 1/10 | 0/6 | 0/4 | 0/4 | 1/4 | 0/5 | 0/5 | 0/5 | ||||
C3H/HeJ | 0/4 | 0/4 | 0/4 | 4/14 | 4/15 | 0/4 | 0/4 | 4/4b | 4/4 | 1/4 | 0/4 | 22.5 | |||
C3H/HeN | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 4/4b | 4/4 | 2/4 | 0/4 | 20.0 | |||
C3H.BphsSJL | 0/4 | 4/4b | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 4/4b | 4/4 | 2/4 | 0/4 | 20.0 |
Animals were sensitized with 200 ng PTX by i.v. injection and challenged 3 days later by i.v. injection of HA (25 mg/kg), 5-HT (0.39 to 50 mg/kg), or BDK (10 to 80 mg/kg). Three or four mice were examined at a given dose. Dosages are based on mg/kg (dry weight) free base or peptide. Deaths were recorded at 30 min, and the results are expressed as the number dead/number studied. LD50s of 5-HT and HA were calculated with GraphPad Prism. Contrasts for combined phenotypes: SM = SJL = AKR = MRL; SM < LG = SJL = AKR = MRL; LG < RFM = PL = DBA/1 = SWR. The significance of differences between carrier- and PTX-treated groups was determined by Fisher's exact test. The significance of differences in LD50s among and between the strains was determined by the extra sum of squares F test. Bpss overall F = 15.9, P < 0.0001; Bpbs overall F = 1.3, P = 0.2.
P = 0.05.
P < 0.0001.
P < 0.01.